Pharmaceuticals The most-up-to-date pharmaceutical news stories, including medical, cosmetic, and supplemental treatments. This section contains releases covering all aspects of the pharmaceutical sector, from research, development, and testing, through to product launches and marketing. Topics include clinical trials and studies, as well as updates on the FDA approval process for new treatment options. Learn about upcoming events, conferences, and educational initiatives. Also included is financial and corporate information from the sector, such as board decisions, appointments and changes, industry awards, and quarterly reports.

Latest

05:00 ET Pharmacy Benefit Management Market Growth Forecast at 6.14% CAGR to 2021 | ReportsnReports

Global pharmacy benefit management market report 2017-2021 provides forecast and analysis of the Global pharmacy benefit management on global and...


04:30 ET Drug Discovery Informatics Market Worth 2.84 Billion USD by 2022

According to a new market research "Drug Discovery Informatics Market by Function (Target Data, Sequencing Data Analysis, Molecular Docking,...


03:30 ET DelSiTech Ltd and C-Tri Co. Ltd Sign a Collaboration Agreement to Develop Innovative Drug Delivery Technology Product for Oncology

DelSiTech Ltd, a Finnish drug delivery technology and development company, and C-Tri Co. Ltd, a Korean KOSDAQ listed biopharmaceutical company,...


01:00 ET Regeneron and ISA Pharmaceuticals Announce Strategic Immuno-Oncology Collaboration

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and ISA Pharmaceuticals B.V., a clinical-stage immunotherapy company, today announced a clinical...


Dec 15, 2017, 22:52 ET ESSA Announces Filing of Prospectus Supplement and an Update to Previously Announced Equity Offering

HOUSTON, TX and VANCOUVER, Dec. 15, 2017 /PRNewswire/ - ESSA Pharma Inc. (TSXV: EPI; NASDAQ: EPIX) ("ESSA" or the "Company") announces an update to...


Dec 15, 2017, 16:30 ET PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on December 11, 2017 it approved non-statutory stock options to purchase an aggregate of...


Dec 15, 2017, 16:15 ET Aratana Therapeutics Announces Study Results for AT-016

Aratana Therapeutics, Inc. (NASDAQ: PETX) has received top-line pivotal field effectiveness study results for AT-016, an investigational...


Dec 15, 2017, 16:10 ET Express Scripts Closes Acquisition Of eviCore; Companies Unite To Improve Healthcare For 100 Million Americans

Express Scripts Holding Company (NASDAQ: ESRX) today announced that it has completed the acquisition of privately held eviCore healthcare, the...


Dec 15, 2017, 16:05 ET QIAGEN and Oxford Immunotec Settle Patent Infringement Lawsuit

QIAGEN N.V. (NASDAQ: QGEN, Frankfurt Stock Exchange: QIA) and Oxford Immunotec Ltd. (NASDAQ: OXFD) announced today that they have reached a...


Dec 15, 2017, 16:01 ET Blueprint Medicines Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares of Common Stock

Blueprint Medicines Corporation (NASDAQ: BPMC), a leader in discovering and developing targeted kinase medicines for patients with genomically...


Dec 15, 2017, 13:15 ET Three Day Course: Advanced Pharmacovigilance (London, United Kingdom - March 7th-9th, 2018)

The "Advanced Pharmacovigilance" conference has been added to Research and Markets' offering. This course will be of maximum benefit to those...


Dec 15, 2017, 12:03 ET Jeffrey R. Lewis, President of Legacy Health Endowment, Shares Helpful Pharma Advice During the Holidays

If you or someone you love are one of the millions of Americans with a chronic disease or a life-threatening condition, pharmaceutical...


Dec 15, 2017, 10:33 ET Concordia International Corp. Comments on Recent Trading Activity

OAKVILLE, ON, Dec. 15, 2017 /PRNewswire/ - Concordia International Corp. ("Concordia" or the "Company") (NASDAQ: CXRX) (TSX: CXR), an international...


Dec 15, 2017, 10:30 ET Global Pipettes and Pipettors Markets 2015-2017 & 2022: Growth Continues Despite Declining Target Candidates for Screening in Pharma Sector

The "Pipettes and Pipettors - Global Strategic Business Report" report has been added to Research and Markets' offering. The report provides...


Dec 15, 2017, 10:17 ET Abbott Raising Quarterly Dividend for 46th Straight Year

The board of directors of Abbott (NYSE: ABT) today increased the company's quarterly common dividend to 28 cents per share from 26.5 cents per...


Dec 15, 2017, 09:23 ET Ultragenyx und Kyowa Kirin geben bekannt, dass Burosumab eine positive Stellungnahme des CHMP zur Behandlung der X-chromosomalen Hypophosphatämie bei Kindern erhalten hat

Bei Zulassung wäre Burosumab die erste gezielte krankheitsmodifizierende Behandlung für XLH Kyowa Hakko Kirin Co., Ltd. (Kyowa Hakko Kirin),...


Dec 15, 2017, 09:00 ET CIRM Grants ViaCyte $1.4M to Create Immune-Evasive Pluripotent Stem Cell Lines

ViaCyte, Inc., a privately-held regenerative medicine company, today announced that the California Institute for Regenerative Medicine (CIRM)...


Dec 15, 2017, 09:00 ET Stoma/Ostomy Care Market Growth Steady at 4.5% CAGR to 2022 | ReportsnReports

Stoma/Ostomy Care Market is forecast to reach $2.99 billion by 2022 from $2.40 billion in 2017 at a CAGR of 4.5% during (2017-2022) driven by the...


Dec 15, 2017, 09:00 ET Ultragenyx et Kyowa Kirin annoncent que burosumab a reçu un avis positif du CHMP pour le traitement du rachitisme hypophosphatémique lié à l'X chez l'enfant

En cas d'approbation, burosumab serait le premier traitement modificateur de la maladie ciblé pour le XLH Kyowa Hakko Kirin Co., Ltd. (Kyowa...


Dec 15, 2017, 08:30 ET Ultragenyx and Kyowa Kirin Announce Burosumab Receives Positive CHMP Opinion for the Treatment of X-Linked Hypophosphatemia in Children

If approved, burosumab would be the first targeted disease-modifying treatment for XLH Kyowa Hakko Kirin Co., Ltd. (Kyowa Hakko Kirin), Kyowa...


Dec 15, 2017, 08:30 ET Kidney / Renal Function Test Market Worth 790.1 Million USD by 2022

According to a new market research report "Kidney/Renal Function Test Market by Product (Dipsticks, Reagents, Disposables), Type (Urine Test...


Dec 15, 2017, 08:30 ET China Biologic Receives Operating Permit for New Collection Facility in Ju County in Shandong Province

China Biologic Products Holdings, Inc. (NASDAQ: CBPO)("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical...


Dec 15, 2017, 08:30 ET MYM Submits Confirmation of Readiness for a License Under the ACMPR to Health Canada for Laval, Quebec Facility

MYM Nutraceuticals Inc., (CSE: MYM) (CSE: MYM.CN) (OTC: MYMMF) (the "Company" or "MYM") is pleased to announce it has submitted the Confirmation of...


Dec 15, 2017, 08:30 ET Ultragenyx y Kyowa Kirin anuncian que burosumab recibe opinión positiva del CHMP

- Ultragenyx y Kyowa Kirin anuncian que burosumab recibe opinión positiva del CHMP para el tratamiento de hipofosfatemia ligada al cromosoma X...


Dec 15, 2017, 07:30 ET Global Precision Medicine Market to Reach $141.70 Billion by 2026, Reports BIS Research

According to a new market intelligence report by BIS Research, titled "Global Precision Medicine Market- Analysis and Forecast, 2017-2026", the...